A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations.
Saved in:
| Title: | A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations. |
|---|---|
| Authors: | Kwag E; East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 35235, Republic of Korea.; Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Kim SD; East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 35235, Republic of Korea.; Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea., Shin SH; Kosin University College of Medicine, Busan 49267, Republic of Korea., Oak C; Kosin University College of Medicine, Busan 49267, Republic of Korea., Park SJ; School of Korean Medicine and Korean Medicine Hospital, Pusan National University, Yangsan 50612, Republic of Korea., Choi JY; School of Korean Medicine and Korean Medicine Hospital, Pusan National University, Yangsan 50612, Republic of Korea., Hoon Yoon S; School of Medicine, Pusan National University Yangsan Hospital, Pusan National University, Yangsan 50612, Republic of Korea., Kang IC; College of Life and Health Sciences and BioChip Research Center, Hoseo University, Asan‑si, Chungcheongnam‑do 336‑795, Republic of Korea., Jeong MK; Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea., Woo Lee H; Ajou University School of Medicine, Suwon 16499, Republic of Korea., Bang SH; Hwirim Korean Medicine Hospital, Busan 48942, Republic of Korea., Son JW; Konyang University Hospital, Daejeon 35365, Republic of Korea., Lee S; Dankook University, Gyeonggi-do 16890, Republic of Korea., Kim SJ; Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Yoo HS; East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 35235, Republic of Korea. |
| Source: | Integrative cancer therapies [Integr Cancer Ther] 2024 Jan-Dec; Vol. 23, pp. 15347354241268231. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 101128834 Publication Model: Print Cited Medium: Internet ISSN: 1552-695X (Electronic) Linking ISSN: 15347354 NLM ISO Abbreviation: Integr Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-695X |
|---|---|
| DOI: | 10.1177/15347354241268231 |
